Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 501

1.

Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer.

Dunlap NE, Yang W, McIntosh A, Sheng K, Benedict SH, Read PW, Larner JM.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1071-7. doi: 10.1016/j.ijrobp.2012.01.088. Epub 2012 Aug 14.

PMID:
22898383
[PubMed - indexed for MEDLINE]
2.

Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.

Burdick MJ, Stephans KL, Reddy CA, Djemil T, Srinivas SM, Videtic GM.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1033-9. doi: 10.1016/j.ijrobp.2009.09.081. Epub 2010 May 14.

PMID:
20472359
[PubMed - indexed for MEDLINE]
3.

Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.

Zhang X, Liu H, Balter P, Allen PK, Komaki R, Pan T, Chuang HH, Chang JY.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1558-65. doi: 10.1016/j.ijrobp.2011.10.035. Epub 2012 May 7.

PMID:
22572078
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients.

Palma DA, van Sörnsen de Koste J, Verbakel WF, Vincent A, Senan S.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):974-8. doi: 10.1016/j.ijrobp.2010.07.025. Epub 2010 Oct 6.

PMID:
20932655
[PubMed - indexed for MEDLINE]
5.

Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.

Ebright MI, Russo GA, Gupta A, Subramaniam RM, Fernando HC, Kachnic LA.

J Thorac Cardiovasc Surg. 2013 Mar;145(3):709-15. doi: 10.1016/j.jtcvs.2012.12.024. Epub 2013 Jan 12.

PMID:
23317944
[PubMed - indexed for MEDLINE]
6.

CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.

Vahdat S, Oermann EK, Collins SP, Yu X, Abedalthagafi M, Debrito P, Suy S, Yousefi S, Gutierrez CJ, Chang T, Banovac F, Anderson ED, Esposito G, Collins BT.

J Hematol Oncol. 2010 Feb 4;3:6. doi: 10.1186/1756-8722-3-6.

PMID:
20132557
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.

Takeda A, Kunieda E, Fujii H, Yokosuka N, Aoki Y, Oooka Y, Oku Y, Ohashi T, Sanuki N, Mizuno T, Ozawa Y.

Lung Cancer. 2013 Mar;79(3):248-53. doi: 10.1016/j.lungcan.2012.11.008. Epub 2012 Dec 11.

PMID:
23246123
[PubMed - indexed for MEDLINE]
8.

Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.

Bollineni VR, Widder J, Pruim J, Langendijk JA, Wiegman EM.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e551-5. doi: 10.1016/j.ijrobp.2012.01.012. Epub 2012 Mar 13.

PMID:
22417800
[PubMed - indexed for MEDLINE]
9.

A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy.

Henderson MA, Hoopes DJ, Fletcher JW, Lin PF, Tann M, Yiannoutsos CT, Williams MD, Fakiris AJ, McGarry RC, Timmerman RD.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):789-95. doi: 10.1016/j.ijrobp.2009.02.051. Epub 2009 May 25.

PMID:
19473777
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.

Guckenberger M, Klement RJ, Kestin LL, Hope AJ, Belderbos J, Werner-Wasik M, Yan D, Sonke JJ, Bissonnette JP, Xiao Y, Grills IS.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1074-81. doi: 10.1016/j.ijrobp.2012.09.016. Epub 2012 Nov 12.

PMID:
23154077
[PubMed - indexed for MEDLINE]
11.

Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.

Lee HY, Lee HJ, Kim YT, Kang CH, Jang BG, Chung DH, Goo JM, Park CM, Lee CH, Kang KW.

J Thorac Oncol. 2010 Apr;5(4):497-503. doi: 10.1097/JTO.0b013e3181d2efe7.

PMID:
20195167
[PubMed - indexed for MEDLINE]
12.

Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning.

Coon D, Gokhale AS, Burton SA, Heron DE, Ozhasoglu C, Christie N.

Clin Lung Cancer. 2008 Jul;9(4):217-21. doi: 10.3816/CLC.2008.n.032.

PMID:
18650169
[PubMed - indexed for MEDLINE]
13.

Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.

Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.

Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.

PMID:
20197344
[PubMed - indexed for MEDLINE]
Free Article
14.

Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm.

Takeda A, Sanuki N, Kunieda E, Ohashi T, Oku Y, Takeda T, Shigematsu N, Kubo A.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):442-8. doi: 10.1016/j.ijrobp.2008.04.043. Epub 2008 Nov 5.

PMID:
18990507
[PubMed - indexed for MEDLINE]
15.

Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.

Nakajima N, Sugawara Y, Kataoka M, Hamamoto Y, Ochi T, Sakai S, Takahashi T, Kajihara M, Teramoto N, Yamashita M, Mochizuki T.

Ann Nucl Med. 2013 Apr;27(3):261-70. doi: 10.1007/s12149-012-0682-4. Epub 2013 Jan 9.

PMID:
23299492
[PubMed - indexed for MEDLINE]
16.

Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.

Werner-Wasik M, Xiao Y, Pequignot E, Curran WJ, Hauck W.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):56-61.

PMID:
11516851
[PubMed - indexed for MEDLINE]
17.

Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.

Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1432-41. Epub 2005 Aug 25.

PMID:
16125870
[PubMed - indexed for MEDLINE]
18.

FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer.

Hoopes DJ, Tann M, Fletcher JW, Forquer JA, Lin PF, Lo SS, Timmerman RD, McGarry RC.

Lung Cancer. 2007 May;56(2):229-34. Epub 2007 Mar 13.

PMID:
17353064
[PubMed - indexed for MEDLINE]
19.

Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients.

Taremi M, Hope A, Dahele M, Pearson S, Fung S, Purdie T, Brade A, Cho J, Sun A, Bissonnette JP, Bezjak A.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):967-73. doi: 10.1016/j.ijrobp.2010.12.039. Epub 2011 Mar 4.

PMID:
21377293
[PubMed - indexed for MEDLINE]
20.

The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT).

Takeda A, Yokosuka N, Ohashi T, Kunieda E, Fujii H, Aoki Y, Sanuki N, Koike N, Ozawa Y.

Radiother Oncol. 2011 Nov;101(2):291-7. doi: 10.1016/j.radonc.2011.08.008. Epub 2011 Aug 31.

PMID:
21889224
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk